Jaren Landen - Chief Clinical Dev. Officer at FILANA THERAPEUTICS, INC.

Issuer-level insider activity

Role
Chief Clinical Dev. Officer
Issuer ticker
FLNA on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Jaren Landen since 10 Aug 2025

Reported holdings for Jaren Landen in FILANA THERAPEUTICS, INC.

Form 4 holding Chief Clinical Dev. Officer

CASSAVA SCIENCES INC

Security class
Stock Option (Right to Buy)
Shares / value
85,000
Estimated value
$1,433,950
Report date
18 Nov 2024
Price
$16.87
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for Jaren Landen in FILANA THERAPEUTICS, INC.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .